Tag Archives: ADHD

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD

FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD Print this page STAMFORD, Conn.–(BUSINESS WIRE) March 01, 2019 –Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for… Read More »

Prenatal Exposure to Valproic Acid: ADHD and Other Deficits in Cognitive Functioning

Previous studies have shown that children exposed to antiepileptic drugs (AEDs) during pregnancy may be at increased risk for neurodevelopmental disorders.  In a recent population-based cohort study from Denmark, researchers examined the prevalence of attention deficit/hyperactivity disorder in children with prenatal exposure to antiepileptic drugs (AEDs).  The conort included all liveborn singleton children born between… Read More »

Is Epilepsy Drug Use in Pregnancy Linked to ADHD?

By E.J. Mundell HealthDay Reporter FRIDAY, Jan. 4, 2019 (HealthDay News) — When a woman with epilepsy uses the anti-seizure drug valproate during a pregnancy, the odds that her baby will go on to develop ADHD rise, a new study suggests. The Danish report can’t prove that valproate causes attention-deficit/hyperactivity disorder (ADHD) in these cases,… Read More »